- Home
- ASUR vs NTHI Comparison
ASUR vs NTHI Comparison
Compare ASUR & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASUR
- NTHI
- Stock Information
- Founded
- ASUR 1985
- NTHI 2008
- Country
- ASUR United States
- NTHI United States
- Employees
- ASUR N/A
- NTHI N/A
- Industry
- ASUR EDP Services
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- ASUR Technology
- NTHI Health Care
- Exchange
- ASUR Nasdaq
- NTHI Nasdaq
- Market Cap
- ASUR 258.8M
- NTHI 211.9M
- IPO Year
- ASUR 1992
- NTHI N/A
- Fundamental
- Price
- ASUR $8.55
- NTHI $10.84
- Analyst Decision
- ASUR Strong Buy
- NTHI
- Analyst Count
- ASUR 6
- NTHI 0
- Target Price
- ASUR $13.42
- NTHI N/A
- AVG Volume (30 Days)
- ASUR 94.4K
- NTHI 97.4K
- Earning Date
- ASUR 10-30-2025
- NTHI 11-19-2025
- Dividend Yield
- ASUR N/A
- NTHI N/A
- EPS Growth
- ASUR N/A
- NTHI N/A
- EPS
- ASUR N/A
- NTHI N/A
- Revenue
- ASUR $125,074,000.00
- NTHI $59,990.00
- Revenue This Year
- ASUR $18.68
- NTHI N/A
- Revenue Next Year
- ASUR $13.03
- NTHI N/A
- P/E Ratio
- ASUR N/A
- NTHI N/A
- Revenue Growth
- ASUR 8.48
- NTHI N/A
- 52 Week Low
- ASUR $7.51
- NTHI $3.20
- 52 Week High
- ASUR $12.74
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- ASUR 57.48
- NTHI N/A
- Support Level
- ASUR $8.01
- NTHI N/A
- Resistance Level
- ASUR $8.45
- NTHI N/A
- Average True Range (ATR)
- ASUR 0.22
- NTHI 0.00
- MACD
- ASUR 0.05
- NTHI 0.00
- Stochastic Oscillator
- ASUR 100.00
- NTHI 0.00
About ASUR Asure Software Inc
Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its HCM products majorly in the United States.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).